Monogram Technologies Inc. (MGRM)
NASDAQ: MGRM · Real-Time Price · USD
2.660
+0.030 (1.14%)
At close: Jun 13, 2025, 4:00 PM
2.710
+0.050 (1.88%)
After-hours: Jun 13, 2025, 7:58 PM EDT
Monogram Technologies Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
27
Market Cap
94.93M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
MGRM News
- 4 weeks ago - Monogram Technologies Inc. (MGRM) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Monogram Technologies Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - Monogram Technologies to Host First Quarter 2025 Results Conference Call on Wednesday, May 14, 2025 at 4:30 p.m. Eastern Time - Accesswire
- 6 weeks ago - CORRECTION FROM SOURCE: Monogram Technologies Receives Regulatory Approval to Start Clinical Trials in India - Accesswire
- 6 weeks ago - Monogram Technologies Granted Regulatory Approval to Import mBôs TKA System for Clinical Investigation in India - Accesswire
- 3 months ago - Monogram Technologies Partners with Urvin to Launch an Exclusive, Verified Shareholder Community - Accesswire
- 3 months ago - Monogram Technologies Announces FDA 510(k) Clearance for the Monogram mBôsTM TKA System - Accesswire
- 3 months ago - Monogram Technologies Inc. (MGRM) Q4 2024 Earnings Call Transcript - Seeking Alpha